InterShunt

About:

InterShunt designs and develops a catheter based minimally-invasive procedure to provide relief for millions suffering from heart failure.

Website: https://intershunt.com/

Top Investors: gbeta, MedTech Innovator, Solas BioVentures, Arsenal Capital Management, Accelerate Venture Partners

Description:

InterShunt designs and develops a catheter-based minimally-invasive procedure to provide relief for millions suffering from heart failure. It believes that left atrial decompression holds the key to reducing symptoms for those who suffer. It also believes that they can do this using a simple catheter procedure. Most importantly, they believe they can do this without the use of an implant. It was founded in 2015 and is headquartered in St Louis, Missouri.

Total Funding Amount:

$8.02M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

St Louis, Missouri, United States

Founded Date:

2015-01-01

Founders:

Gil Vardi

Number of Employees:

1-10

Last Funding Date:

2023-06-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai